Chemical and Pharmaceutical Bulletin p. 247 - 255 (1995)
Update date:2022-08-04
Topics:
Seki
Takezaki
Ohuchi
Ohuyabu
Tanimoto
Yamaguchi
Saitoh
Ishimori
Yasuda
A series of phenoxypropanolamines having a hydrazinopyridazinyl moiety was synthesized. Their hypotensive and β-blocking activities were evaluated after intravenous administration of the compounds to anesthetized rats. Some of them exhibited both activities. In particular, compound 20k is a candidate for clinical use due to its hypotensive activity, equal to that of hydralazine, and its β-blocking activity, 2.7-fold more potent than that of propranolol.
View MoreNanjing Legend Pharmaceutical & Chemical Co., Ltd.
Contact:+86-25-83767696
Address:14-7 Zhongshan Lu Guluo District, Nanjing
Wuxi Innopal International Trade CO.,LTD
Contact:+86-510-80711901-8003
Address:Room 402,Building 5,Longze Garden,No.17,South huanjiu Road,Yixing City, Jiangsu,China
Beijing Stable Chemcial Co.ltd
Contact:86-10-63785052
Address:A1301 Technological Edifice. No.4 FuFeng Road,FengTai District, Beijing. China
Shijiazhuang Yunxuan Im&Export Co.,Ltd.
Contact:+86-311-83037514
Address:No.6 Hongbin Road
Contact:+86-021-50792271
Address:Building 24A, 300 Chuantu Road, Chuansha, Pudong new area, Shanghai, China, 201202
Doi:10.1021/ic060111k
(2006)Doi:10.1016/S0040-4039(00)88392-6
(1983)Doi:10.1248/cpb.53.492
(2005)Doi:10.1021/jm051263c
(2006)Doi:10.1016/j.tetlet.2006.03.175
(2006)Doi:10.1021/jo980451q
(1998)
